Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

67.01
+1.542.35%
Post-market: 67.020.0100+0.01%19:59 EDT
Volume:6.84M
Turnover:457.82M
Market Cap:136.42B
PE:14.75
High:67.55
Open:65.79
Low:65.13
Close:65.47
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.72
T/O Rate:0.34%
Dividend:2.51
Dividend Rate:3.74%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:6.11
PE(LYR):19.37

Loading ...

AstraZeneca Shares Down 2.75% on Tradegate

THOMSON REUTERS
·
Aug 03

LIVE MARKETS-Europe Before the Bell: Peace Deal Hopes, Again

Reuters
·
Aug 03

UK Stocks-Factors to Watch on August 3

Reuters
·
Aug 03

PRESS DIGEST-Financial Times - August 3

Reuters
·
Aug 03

Movement Alert|Bristol-Myers Squibb Rises 3.28% Overnight, AstraZeneca Reportedly in Merger Talks That Could Create Largest Pharma Deal in History

Market Focus
·
Aug 03

AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says

TIPRANKS
·
Aug 03

AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape

Stock News
·
Aug 03

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger

Benzinga_recent_news
·
Aug 03

AstraZeneca Holds Talks with Bristol Myers Squibb on Pharma Megadeal- FT

THOMSON REUTERS
·
Aug 03

Bristol-Myers Squibb's Catalyst Delays May Keep Stock Range-Bound, RBC Says

MT Newswires Live
·
Aug 01

Bristol-Myers Squibb is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 31

Ratio Therapeutics Announced Closing of a $70 Million Series C Financing

Reuters
·
Jul 31

Ratio Therapeutics: Financing Included Participation from Bristol Myers Squibb, Eli Lilly and Company, Wasatch Group & More

THOMSON REUTERS
·
Jul 31

Street View: Bristol Myers Keeps the Ball Rolling on Growth and Pipeline Promise

Reuters
·
Jul 31

Truist Raises Price Target on Bristol-Myers Squibb to $70 From $65, Keeps Buy Rating

MT Newswires Live
·
Jul 31

U.S. Research ROUNDUP-Apple, Amazon, Mastercard

Reuters
·
Jul 31

Bristol-Myers Squibb Co : Truist Securities Raises Target Price to $70 from $65

THOMSON REUTERS
·
Jul 31

Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 31

Bristol-Myers Boosts 2026 Guidance on Portfolio Strength

Benzinga Earnings
·
Jul 31

Bristol-Myers Squibb Co Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31